CALCiViS News

FDA filing on track for H2 2017

Edinburgh, 05 June 2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that it has completed patient recruitment into its PMA clinical study assessing the safety and performance of a commercial version the CALCiViS ® imaging system for...

CALCiViS starts new FDA clinical study

Edinburgh, 09 January   2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that it has begun recruitment into a clinical study of approximately 100 patients assessing the performance of a commercial version of its CE marked CALCiViS imaging...

CALCiViS at Medtech Showcase 2017

Edinburgh, 10 January 2017 - CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that Chief Executive Officer (CEO), Adam Christie, will present at the Medtech Showcase held at the 9th Annual Biotech Showcase™ today Tuesday, January 10th 2017 at...

CALCiViS at 2016 Organisation for Caries Research

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, presented new clinical and experimental data for the CALCiViS imaging system at the 63rd Congress of the European Organisation for Caries Research (ORCA) in Athens, Greece on 6-9 July 2016. CALCiViS presented...

CALCiViS wins place on London Stock Exchange’s ELITE Programme

Edinburgh, 26th April 2016 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, today announces that it has been accepted into the next cohort of the London Stock Exchange (LSE)’s ELITE programme that supports ambitious companies towards growth and investment....

CALCiViS imaging system showcases at the 2016 Chicago Dental Society

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, showcases a prototype of its CALCiViS imaging system at the 151st Meeting of the Chicago Dental Society, held in Chicago, USA. The CALCiViS imaging system is the first device to allow dentists...

CALCiViS appoints Peter Rees as a Non-Executive Board Director

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, today announces it has appointed Peter Rees as non-executive Board Director. Mr. Rees’s extensive experience of the dental market, in particular his demonstrated track record in sales and marketing and product launches,...

CALCiViS raises £4.5m for Development of the CALCIVIS imaging system

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, today announces it has secured £4.5m in new equity and grant funding. Existing funders, Archangel Investors and the Scottish Investment Bank, have invested a further £2.6m in the Company. CALCiViS has also...

Clinical Study of CALCiViS imaging system completed

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay, today announces that it has completed a first clinical study of its CALCiViS imaging system. The CALCiViS imaging system is a sophisticated medical device and consumable combination designed to transform the assessment and management of enamel...

CALCiViS Represented at the International Association for Dental Research

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay, today announces its CALCiViS imaging system will be presented at two international dental conferences in the coming weeks. CALCiViS Chief Technical Officer, Bruce Vernon, is giving a presentation on the development of the system at the...
Web Design by: Purple Imp